One-year outcomes of long-acting cabotegravir and rilpivirine in people living with HIV and a long exposure to antiretroviral therapy: data from the SCohoLART Study

AUTHORS

C. Muccini¹, N. Gianotti¹, S. Diotallevi¹, R. Lolatto¹, V. Spagnuolo¹, D. Canetti¹, S. Bagaglio¹, V. Gordo Perez¹, T. Clemente², M. Bottanelli², C. Candela², S. Nozza^1,2, A. Castagna^1,2


INSTITUTIONS

¹IRCCS San Raffaele Scientific Institute, Department of Infectious Diseases, Milan, Italy, ²Vita-Salute San Raffaele University, Milan, Italy